Comparing Opdivo vs Tecentriq
| Opdivo | Tecentriq |
|
|---|
| Opdivo (nivolumab) | Tecentriq (atezolizumab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Opdivo is an immune checkpoint inhibitor that may be used to treat many different cancers including melanoma, liver cancer, and lung cancer. Fatigue, skin conditions, a cough, upper respiratory tract... View more |
Prescription only
Prescribed for Hepatocellular Carcinoma, Small Cell Lung Cancer, Alveolar Soft Part Sarcoma, Melanoma, Non-Small Cell Lung Cancer. Tecentriq may also be used for purposes not listed in this medication guide. View more |
Related suggestions Melanoma
Popular comparisons
|
|||||||||||||||
| More about Opdivo (nivolumab) | More about Tecentriq (atezolizumab) | ||||||||||||||||
| Generic Status | |||||||||||||||||
|
No lower-cost generic available |
No lower-cost generic available |
||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Opdivo has an average rating of 4.8 out of 10 from a total of 78 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 53% reported a negative effect. |
Tecentriq has an average rating of 0.0 out of 10 from a total of 1 ratings on Drugs.com. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
See also: Opdivo side effects in more detail. |
Common side effects include:
See also: Tecentriq side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Opdivo prices |
View all Tecentriq prices |
||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
640.8 hours |
648 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 19 drugs are known to interact with Opdivo:
|
A total of 147 drugs are known to interact with Tecentriq:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
December 22, 2014 |
May 18, 2016 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.